Calreticulin expression controls cellular redox, stemness, and radiosensitivity to function as a novel adjuvant for radiotherapy in neuroblastoma

HIGHLIGHTS

  • who: Chih-Jung Chen and colleagues from the Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan School of Medicine, Shan Medical University, Taichung, Taiwan have published the Article: Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma, in the Journal: Oxidative Medicine and Cellular Longevity of 11/07/2022
  • what: In present study, the authors explored whether CALR could be impacted by irradiation or mediate cancer malignancies of NB.
  • how: The data showed that both transient siCALR and KDCALR resulted . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?